Mpox – Sexual Networks, HIV and Activism
Efficacy is Not the Only HIV Prevention Attribute that Matters – Lessons from Contraception
CROI and Community and YOU – Preparing for CROI 2023
Status Updates on Ongoing and Planned HIV Prevention Trials
The world is grappling with the far-reaching impacts of the COVID-19 pandemic and the HIV prevention field is no different. Most trials investigating new biomedical HIV prevention products have paused, citing concerns for the safety of trial participants and the study teams.
How COVID-19 is impacting research varies by trial and site, and efforts are ongoing to minimize impact on trial timelines and data. AVAC will continue to monitor developments—watch this space.
Ongoing Studies for the Treatment and Prevention of the COVID-19 Virus
This table is a work in progress, as this is an incredibly dynamic landscape. Over the past month, the scientific community has accelerated development of COVID-19 diagnostics, therapeutics and a potential vaccine. This document also links to a number of resources available to track these developments.
In addition, a collaborative project of the COVID-19 Working Group NY, the PrEP4All Collaboration and Treatment Action Group offers concise overviews and analyses of key research areas.
AIDS Vaccines by the Numbers: Trials, discoveries, money and more
We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward. The graphics below represent key facts about the AIDS vaccine field.
Tracking and Translating the Field
Bridging the scientific field and communities where research happens
Been There, Did That – Research Reflections from CROI 2023
Thursday, March 23 at 10:00–11:30am ET
Speakers included community leaders and researchers reflecting on the most interesting, consequential science presented at CROI 2023.
Co-moderated by Devan Nambiar, Gay Men’s Sexual Health Alliance and CROI 2023 Community Educator Scholar
Featured researcher:
Dr. Monica Gandhi, UCSF
Featured community speakers:
CROI 2023 Community Educator Scholars
Recording / Dr. Monica Ghandi’s Slides / Community Educator Slides
Avac Event
When Cure Means Control
An introduction to viral control off therapy
Tuesday, March 28 at 9:00 am ET
As the number of cure-related clinical trials grows, so does the number of people experiencing month-long delays in viral rebound. A very small handful of participants remain off therapy long after the trial ends. These individuals who can control HIV without therapy after an intervention are known as controllers.
This webinar will:
- Introduce the concept of viral control off therapy
- Provide a platform to ask experts questions on HIV control
- Introduce key issues advocates should be following
Featuring Jon LI, Harvard University; Marina Caskey, Rockefeller University; Ann Chahroudi, Emory School of Medicine, Josephine Nabukenya, EGPAF Board Member and IAS Governing Council Member, and moderated by Jessica Salzwedel, AVAC
Avac Event
Been There, Did That – Research Reflections from CROI 2023
Thursday, March 23 at 10:00–11:30am ET
Speakers will include community leaders and researchers reflecting on the most interesting, consequential science presented at CROI 2023.
Co-moderated by Devan Nambiar, Gay Men’s Sexual Health Alliance and CROI 2023 Community Educator Scholar
Featured researcher:
Dr. Monica Gandhi, UCSF
Featured community speakers:
CROI 2023 Community Educator Scholars
This webinar is a part of The Choice Agenda.